Sha Z - Search Results

1

Proto-oncogenic miR-744 is upregulated by transcription factor c-Jun via a promoter activation mechanism.

Sha Z, Zhu X, Li N, Li Y, Li D. Sha Z, et al. Oncotarget. 2016 Oct 4;7(40):64977-64986. doi: 10.18632/oncotarget.11285. Oncotarget. 2016. PMID: 27533465 Free PMC article.

2

[Risk factors of level Ib lymphadenopathy in nasopharyngeal carcinoma].

Yuan G, Zheng X, Zhu X, Wang Z, Song W, Zhang H, Sha Z. Yuan G, et al. Among authors: sha z. Nan Fang Yi Ke Da Xue Xue Bao. 2014 Jun;34(7):983-7. Nan Fang Yi Ke Da Xue Xue Bao. 2014. PMID: 25057069 Chinese.

3

Should KRAS mutation still be used as a routine predictor of response to EGFR-TKIs in advanced non-small-cell lung cancer? A revaluation based on meta-analysis.

Ying M, Zhu X, Chen K, Sha Z, Chen L. Ying M, et al. Among authors: sha z. J Cancer Res Clin Oncol. 2015 Aug;141(8):1427-39. doi: 10.1007/s00432-015-1910-9. Epub 2015 Jan 11. J Cancer Res Clin Oncol. 2015. PMID: 25577224

4

MiR-744 functions as a proto-oncogene in nasopharyngeal carcinoma progression and metastasis via transcriptional control of ARHGAP5.

Fang Y, Zhu X, Wang J, Li N, Li D, Sakib N, Sha Z, Song W. Fang Y, et al. Among authors: sha z. Oncotarget. 2015 May 30;6(15):13164-75. doi: 10.18632/oncotarget.3754. Oncotarget. 2015. PMID: 25961434 Free PMC article.

5

miR-125a-3p targets MTA1 to suppress NSCLC cell proliferation, migration, and invasion.

Zhang H, Zhu X, Li N, Li D, Sha Z, Zheng X, Wang H. Zhang H, et al. Among authors: sha z. Acta Biochim Biophys Sin (Shanghai). 2015 Jul;47(7):496-503. doi: 10.1093/abbs/gmv039. Epub 2015 May 21. Acta Biochim Biophys Sin (Shanghai). 2015. PMID: 25998575 Free article.

6

Transcription factor CDX2 up-regulates proto-oncogenic miR-744 via a promoter activation mechanism in non-small-cell lung cancer.

Sha Z, Hao S, Long F, Wei Y, Chen S, Li T, Yi L, Hu L, Lin Z, Xian J, Pei X. Sha Z, et al. Ann Transl Med. 2021 Oct;9(20):1538. doi: 10.21037/atm-21-4526. Ann Transl Med. 2021. PMID: 34790744 Free PMC article.

7

Treatment Patterns and Survival of Patients With Advanced Non-Small Cell Lung Cancer Guided by Comprehensive Genomic Profiling: Real-World Single-Institute Study in China.

Lv W, Cheng H, Shao D, Wei Y, Zhu W, Wu K, Jiang W, Hu L, Sha Z, Zhong B, Pei X. Lv W, et al. Among authors: sha z. Front Oncol. 2021 Mar 10;11:630717. doi: 10.3389/fonc.2021.630717. eCollection 2021. Front Oncol. 2021. PMID: 33777783 Free PMC article.

8

Mechanism study on pH-responsive cyclodextrin capped mesoporous silica: effect of different stalk densities and the type of cyclodextrin.

Bai L, Zhao Q, Wang J, Gao Y, Sha Z, Di D, Han N, Wang Y, Zhang J, Wang S. Bai L, et al. Among authors: sha z. Nanotechnology. 2015 Apr 24;26(16):165704. doi: 10.1088/0957-4484/26/16/165704. Epub 2015 Apr 1. Nanotechnology. 2015. PMID: 25827241

9

Clinical observation of Pemetrexed first-line treatment in advanced non-squamous lung cancer or non-small cell lung cancer without driver-mutations: a phase 2, single-arm trial.

Sha Z, He JB, Jiang Q, Xu L, Hu L, Liang Z, Li T, Lin Z, Yu Q, Pei X, Lv W. Sha Z, et al. Ann Transl Med. 2020 Oct;8(20):1315. doi: 10.21037/atm-20-6539. Ann Transl Med. 2020. PMID: 33209895 Free PMC article.

10

Clinical observation of pulmonary lymphoepithelioma-like carcinoma.

Sha Z, Wei Y, Gao T, Luo Y, Chen J, Li T, Hu L, Niu X, Lin Z, Lv W, Pei X. Sha Z, et al. J Thorac Dis. 2021 Oct;13(10):5683-5690. doi: 10.21037/jtd-21-1369. J Thorac Dis. 2021. PMID: 34795918 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

510 results

Search Page

Filters